Telesis Bio, Inc. (TBIO) - רווח עתידי חזוי

The projected profit volume on GURU.Markets contains data where indicates the current level. High bankruptcy risk due to a lack of funds and the slow implementation of DNA synthesis systems is weighing on Telesis Bio, Inc. (TBIO) quotes. However, the decentralization of biomaterial supplies to client laboratories should increase margins. Attracting leading bioengineers ensures the company's technological progress and scientific potential.
TBIO (Telesis Bio, Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים

This financial performance forecast reflects the potential of Telesis Bio, Inc. (TBIO) within the DNA synthesis segment. The metric captures the expected long-term business returns, accounting for macroeconomic risks and the cost of capital. The calculation is based on cash flow dynamics and structural market shifts. Localizing assembly in California reduces operating expenses, directly impacting the accuracy of these valuations. This indicator helps determine the fair value of the shares, eliminating the risk of overpayment.